Showing results (31-40 of 65) with videos related to
Sort By:
Pageof 7
General Pharmacology|March 24, 1998
Antimalarial drugs inhibit phospholipase A2 activation and induction of interleukin 1beta and tumor necrosis factor alpha in macrophages: implications for their mode of action in rheumatoid arthritisJ Bondeson, R SundlerJournal of the Royal Society of Medicine|July 1, 1996
The hairy family of Burma: a four generation pedigree of congenital hypertrichosis lanuginosaJ Bondeson, A E MilesActa Ophthalmologica Scandinavica|May 4, 2000
Comparison of ranked segment analysis (RSA) and cup to disc ratio in computer-assisted optic disc evaluationK G Gundersen, P AsmanInternational Journal of Clinical Practice|May 16, 2001
Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE)J Bondeson, R N MainiAmerican Journal of Medical Genetics|August 15, 1993
Julia Pastrana, the nondescript: an example of congenital, generalized hypertrichosis terminalis with gingival hyperplasiaJ Bondeson, A E MilesBiochimica Et Biophysica Acta|October 17, 1984
Proton-induced membrane fusion. Role of phospholipid composition and protein-mediated intermembrane contactJ Bondeson, J Wijkander, R SundlerActa Ophthalmologica Scandinavica|April 4, 1998
A perimetric learner's indexJ Olsson, P Asman, A HeijlArchives of Ophthalmology (Chicago, Ill. : 1960)|February 1, 1989
Visual field interpretation with empiric probability mapsA Heijl, G Lindgren, J Olsson, et al.Clinical and Experimental Rheumatology|April 16, 1998
Polymyositis associated with asymptomatic primary biliary cirrhosisJ Bondeson, B Veress, Y Lindroth, et al.Proceedings of the National Academy of Sciences of the United States of America|May 13, 1999
Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediatorsJ Bondeson, B Foxwell, F Brennan, et al.Pageof 7